Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
0.9226
-0.0774 (-7.74%)
At close: Nov 20, 2026, 4:00 PM EST
0.9300
+0.0074 (0.80%)
After-hours: Nov 20, 2026, 7:45 PM EST
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $20.19 million as of November 20, 2026. It is the 36,309th most valuable company in the world and the 5,082nd biggest in the United States. Its market cap has decreased by 91.13% in one year.
Market Cap
20.19M
Enterprise Value
-39.59M
1-Year Change
-91.13%
Global Rank
Country Rank
#5,082 United States
Category
ChartMarket Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $20.19M, a decrease of -94.10%. That is a compound annual growth rate of -79.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 20.19M | -92.93% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 (IPO) | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 25.58M |
| Lite Strategy | 24.99M |
| Polyrizon | 24.69M |
| GridAI Technologies | 24.43M |
| Metagenomi Therapeutics | 23.21M |
| LeonaBio | 23.18M |
| ABVC BioPharma | 23.10M |
| TransCode Therapeutics | 22.50M |